Favipiravir (sodium)
Product Specifications
UNSPSC Description
Favipiravir (T-705) sodium is an inhibitor of viral RNA polymerase (RNA polymerase), which is converted into its active form Favipiravir-ribofuranosyl-5′-triphosphate (RTP). Favipiravir-RTP inhibits the activity of influenza virus RNA-dependent RNA polymerase (RdRP) with an IC50 of 341 nM[1][2].
Target Antigen
Bacterial; DNA/RNA Synthesis; Influenza Virus; SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection;Cell Cycle/DNA Damage
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/favipiravir-sodium.html
Smiles
O=C(C1=NC(F)=CN=C1O[Na])N
Molecular Weight
179.08
References & Citations
[1]Furuta Y, et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res. 2013 Nov;100(2):446-54.|[2]Rocha-Pereira J, et al. Favipiravir (T-705) inhibits in vitro norovirus replication. Biochem Biophys Res Commun. 2012 Aug 10;424(4):777-80.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-14768A/Favipiravir-sodium-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-14768A/
Clinical Information
Phase 4
CAS Number
1366418-99-6
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
